BEZZERRI, VALENTINO
 Distribuzione geografica
Continente #
NA - Nord America 138
AS - Asia 122
EU - Europa 28
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 291
Nazione #
US - Stati Uniti d'America 138
CN - Cina 61
SG - Singapore 53
IT - Italia 12
DE - Germania 3
MY - Malesia 3
BE - Belgio 2
ES - Italia 2
FI - Finlandia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
CH - Svizzera 1
CO - Colombia 1
EG - Egitto 1
GR - Grecia 1
IE - Irlanda 1
IL - Israele 1
LV - Lettonia 1
PK - Pakistan 1
PL - Polonia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
Totale 291
Città #
West Jordan 110
Guangzhou 57
Singapore 32
Boardman 20
Ferrara 5
Modena 3
Ponte San Pietro 3
Ashburn 2
Brussels 2
Helsinki 2
Athens 1
Bogotá 1
Cairo 1
Dubai 1
Dublin 1
Islamabad 1
Munich 1
Riga 1
Riyadh 1
Rome 1
Shenzhen 1
Tel Aviv 1
Vienna 1
Warsaw 1
Yerevan 1
Zurich 1
Totale 252
Nome #
Method of treatment of shwachman-diamond syndrome 15
Shwachman-Diamond syndromes: clinical, genetic, and biochemical insights from the rare variants 12
Differential Effects of Angelicin Analogues on NF-κB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 12
Trimethylangelicin reduces IL-8 transcription and potentiates CFTR function 11
Nonsense suppression therapy: New hypothesis for the treatment of inherited bone marrow failure syndromes 11
Cystic fibrosis: New therapeutic horizons 10
Silencing of genes coding for transcription factors: Biological effects of decoy oligonucleotides on cystic fibrosis bronchial epithelial cells 10
Is cellular senescence involved in cystic fibrosis? 10
Novel Translational Read-Through–Inducing Drugs as A Therapeutic Option for Shwachman-Diamond Syndrome 10
Shwachman-Diamond Syndrome: Molecular Mechanisms and Current Perspectives 10
Decoy oligodeoxyribonucleotides and peptide nucleic acids-DNA chimeras targeting nuclear factor kappa-B: Inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa 10
Further insights into the hematological disorders observed in Shwachman-Diamond syndrome: mTOR and STAT3 hyper-phosphorylation in CD4+ and CD8+ T cells and efficacy of rapamycin treatment 10
The Molecular and Genetic Mechanisms of Inherited Bone Marrow Failure Syndromes: The Role of Inflammatory Cytokines in Their Pathogenesis 9
A Signature of Differentially Expressed Micrornas in Lymphoblastoid Cells from Shwachman-Diamond Syndrome Patients Indicates Possible Molecular Targets for Mirna Therapeutics 9
Study of Angiogenic Potential and Oxidative Metabolism in Mesenchymal Stromal Cells Derived from Shwachman-Diamond Syndrome Patients 9
Antioxidants As a Novel Treatment to Revert Impaired Angiogenic Potential Driven By Metabolic Alterations Observed in Shwachman-Diamond Syndrome Derived Mesenchymal Stromal Cells 9
Deletion of eif6 Partially Rescues Survival, but Not Neutropenia, of Zebrafish Model of Shwachman-Diamond Syndrome: The Roles of Sbds and Eif6 in Perturbing Lipid Metabolism 8
A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients 6
Docking of molecules identified in bioactive medicinal plants extracts into the p50 NF-kappaB transcription factor: Correlation with inhibition of NF-kappaB/DNA interactions and inhibitory effects on IL-8 gene expression 6
Interaction of adenovirus type 5 fiber with the coxsackievirus and adenovirus receptor activates inflammatory response in human respiratory cells 6
Mapping the transcriptional machinery of the IL-8 gene in human bronchial epithelial cells 6
Trimethylangelicin promotes the functional rescue of mutant F508del CFTR protein in cystic fibrosis airway cells 6
Late generation lentiviral vectors: Evaluation of inflammatory potential in human airway epithelial cells 6
Modulators of sphingolipid metabolism reduce lung inflammation 6
Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman–Diamond syndrome cells 6
Anti-inflammatory effect of miglustat in bronchial epithelial cells 6
Targeting transcription factor activity as a strategy to inhibit pro-inflammatory genes involved in cystic fibrosis: Decoy oligonucleotides and low-molecular weight compounds 6
Does cystic fibrosis constitute an advantage in COVID-19 infection? 5
Enhanced P53 levels are involved in the reduced mineralization capacity of osteoblasts derived from shwachman–diamond syndrome subjects 5
Effects of decoy molecules targeting NFkappaB transcription factors in Cystic fibrosis IB3-1 cells: Recruitment of NFkappaB to the IL-8 gene promoter and transcription of the IL-8 gene 5
An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system 5
Counteracting the Common Shwachman–Diamond Syndrome-Causing SBDS c.258+2T>C Mutation by RNA Therapeutics and Base/Prime Editing 5
Induction of IL-6 gene expression in a CF bronchial epithelial cell line by Pseudomonas aeruginosa is dependent on transcription factors belonging to the Sp1 superfamily 5
Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of pro-inflammatory genes in bronchial epithelial cells 5
Transient receptor potential ankyrin 1 channels modulate inflammatory response in respiratory cells from patients with cystic fibrosis 5
Ataluren-driven restoration of Shwachman-Bodian-Diamond syndrome protein function in Shwachman-Diamond syndrome bone marrow cells 5
β-Sitosterol reduces the expression of chemotactic cytokine genes in cystic fibrosis bronchial epithelial cells 4
SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation 4
Pseudomonas aeruginosa reduces the expression of CFTR via post-translational modification of NHERF1 4
Virtual screening against p50 NF-κB transcription factor for the identification of inhibitors of the NF-κB-DNA interaction and expression of NF-κB upregulated genes 4
The pathogenic variant c.258+533_459+403del in SBDS gene is the commonest rare variant in Italy and shows a founder effect 4
Transcription factor oligodeoxynucleotides to NF-κB inhibit transcription of IL-8 in bronchial cells 4
Phospholipase C-β3 is a key modulator of IL-8 expression in cystic fibrosis bronchial epithelial cells 4
Modulation of expression of IL-8 gene in bronchial epithelial cells by 5-methoxypsoralen 4
MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells 4
GBA2-encoded β-glucosidase activity is involved in the inflammatory response to Pseudomonas aeruginosa 4
Expression of microRNA-93 and interleukin-8 during Pseudomonas aeruginosa-mediated induction of proinflammatory responses 4
MTOR and STAT3 pathway hyper-activation is associated with elevated interleukin-6 levels in patients with shwachman-diamond syndrome: Further evidence of lymphoid lineage impairment 3
Regulation of IL-8 gene expression in gliomas by microRNA miR-93 3
Peripheral blood immunophenotyping in a large cohort of patients with Shwachman–Diamond syndrome 3
miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma 3
Antibacterial and anti-inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis 3
New insights into the Shwachman-Diamond Syndrome-related haematological disorder: Hyper-activation of mTOR and STAT3 in leukocytes 2
Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221 2
Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation 2
PLCB3 loss of function reduces Pseudomonas aeruginosa-dependent IL-8 release in cystic fibrosis 2
Mitochondrial Ca2+-dependent NLRP3 activation exacerbates the Pseudomonas aeruginosa-driven inflammatory response in cystic fibrosis 2
Totale 349
Categoria #
all - tutte 3.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.652


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024260 0 0 0 0 0 0 0 0 58 113 66 23
2024/202589 23 60 6 0 0 0 0 0 0 0 0 0
Totale 349